Revision history of "Chronic Vardenafil Therapy Has CV Advantages In Type 2 Diabetes"

Jump to navigation Jump to search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 02:30, 15 July 2019LorriGlynde3294 (talk | contribs). . (5,936 bytes) (+5,936). . (Created page with "<br> DUBLIN — Chronic remedy with the phosphodiesterase-5 (PDE-5) inhibitor vardenafil (Levitra, Bayer/GlaxoSmithKline) for six months in males with sort 2 diabetes is se...")